Joseph S. Zakrzewski, Director at Cyteir Therapeutics, Inc. (CYT), bought 1,100 shares at $9.85 ($11K) on 2021-12-28, disclosed to the SEC on 2021-12-28.
Open-market purchase of $11k CYT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.87 | 200 | $2K | 18.1% |
| 2 | $9.97 | 200 | $2K | 18.3% |
| 3 | $10.18 | 99 | $1K | 9.2% |
| 4 | $9.85 | 601 | $6K | 54.3% |
| Total | $9.91 avg | 1,100 | $11K | 100% |
| Filing → |
| ANTX | SELL | 2024-01-19 | $1.9M | — | Filing → |
| CYT | BUY | 2022-12-08 | $28K | — | Filing → |
| CYT | BUY | 2022-05-16 | $1K | — | Filing → |